Izraēla - ivrits - Ministry of Health

novartis israel ltd - siponimod as fumaric acid - טבליות מצופות פילם - siponimod as fumaric acid 0.25 mg - siponimod

Izraēla - ivrits - Ministry of Health

novartis israel ltd - siponimod as fumaric acid - טבליות מצופות פילם - siponimod as fumaric acid 2 mg - siponimod

Izraēla - ivrits - Ministry of Health

novartis israel ltd - glyceryl trinitrate - מדבקות - glyceryl trinitrate 25 mg/patch - glyceryl trinitrate - glyceryl trinitrate - prophylaxis of angina pectoris.

Izraēla - ivrits - Ministry of Health

novartis israel ltd - glyceryl trinitrate - מדבקות - glyceryl trinitrate 25 mg/patch - glyceryl trinitrate - glyceryl trinitrate - prophylaxis of angina pectoris.

Izraēla - ivrits - Ministry of Health

novartis israel ltd - glyceryl trinitrate - מדבקות - glyceryl trinitrate 50 mg/patch - glyceryl trinitrate - glyceryl trinitrate - prophylaxis of angina pectoris.

Izraēla - ivrits - Ministry of Health

novartis israel ltd - glyceryl trinitrate - מדבקות - glyceryl trinitrate 50 mg/patch - glyceryl trinitrate - glyceryl trinitrate - prophylaxis of angina pectoris.

Izraēla - ivrits - Ministry of Health

novartis israel ltd - metoprolol tartrate - טבליות בשחרור איטי - metoprolol tartrate 200 mg - metoprolol - metoprolol - hypertension, angina pectoris, arrhythmia, prophylaxis of migrain, prophylaxis of reinfarction.

Izraēla - ivrits - Ministry of Health

novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.1 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.

Izraēla - ivrits - Ministry of Health

novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.2 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.

Izraēla - ivrits - Ministry of Health

novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.05 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.